Bioactive conformational ensemble server and database. A public framework to speed up in silico drug discovery. by Zivanovic, Sanja et al.
BIOACTIVE CONFORMATIONAL ENSEMBLE SERVER 
AND DATABASE. A PUBLIC FRAMEWORK TO SPEED  
UP IN SILICO DRUG DISCOVERY 
 
Sanja Zivanovic1, Genís Bayarri1, Francesco Colizzi1, David Moreno1,  




Modern high-throughput structure-based drug discovery algorithms consider ligand flexibility, but 
typically with low accuracy, which results in a loss of performance in the derived models. Here we 
present the Bioactive Conformational Ensemble (BCE) server and its associated database. The server 
creates conformational ensembles of drug-like ligands and stores them in the BCE database, where 
a variety of analyses are offered to the user. The workflow implemented in the BCE server combines 
enhanced sampling molecular dynamics with self-consistent reaction field quantum mechanics 
(SCRF/QM) calculations. The server automatizes all the steps to transform 1D or 2D representation 
of drugs into three dimensional molecules, which are then titrated, parametrized, hydrated and 
optimized before being subjected to Hamiltonian replica-exchange (HREX) molecular dynamics 
simulations. Ensembles are collected and subjected to a clustering procedure to derive 
representative conformers, which are then analyzed at the SCRF/QM level of theory. All structural 
data is organized in a noSQL database accessible through a graphical interface and in a 
programmatic manner through a REST API. The server allows the user to define a private workspace 
and offers a deposition protocol as well as input files for “in house” calculations in those cases where 
confidentiality is a must. The database and the associated server are available at  
https://mmb.irbbarcelona.org/BCE   
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Computer-aided drug design (CADD) speeds-up the discovery and optimization of new active 
compounds through a large variety of methods, usually based on predicting whether a given 
molecule will bind to a biological target 1,2. A good binding is the result of a subttle balance between 
different terms: a small desolvation contribution, favorable ligand-receptor interaction terms and a 
small cost for the ligand to adopt the “bioactive” contormation. The transfer from solution to the 
binding sites implies a reduction in the conformational space and the sampling of conformation that 
may not be the most stable one in solution, which means that drugs with high affinity are usually 
those whose preferred conformation in solution is close to that required to bind the receptor. Thus, 
to be efficient, CADD approaches, either ligand- or structure-based, must be accurate at predicting 
the penalty paid by the ligand to achieve its protein-bound state (a process known as conformer 
focussing), as errors in this term ruin the accuracy of any scoring function 3. Conformer focussing 
can be defined as the free energy associated to the transition of the ligand from the free state in 
solution to the “bound conformation”, i.e. the log of the probability of finding the bioactive 
coformation(s) within the unbound conformational ensemble of the ligand. In other words, 
determining the cost of reaching the bioactive conformation requires the knowledge of the 
conformational ensemble of the unbound ligand in solution, something that can be complex to 
define for flexible ligands 4.  
 
Currently available methods for obtaining the conformational ensembles of unbound ligands can be 
classified as physical or knowledge-based 5,6. The first family of methods implement systematic or 
stochastic searching schemes involving the use of force-fields in expensive calculations whose 
quality depends on the extent of sampling and on the accuracy of the force-field. On the other hand, 
knowledge-based methods rely on experimental data available in public databases, and can produce 
a large number of conformers with relatively small computational cost 7. A variety of computer 
programs implementing physical or knowledge-based algorithms for exploration of the unbound 
state of the ligand are available, some of them as open-source codes, other as part of commercial 
modelling software 8. These packages are fast and easy to use within automatic workflows, but often 
the results are not accurate due to the simplicity of the knowledge rules or the energy 
functionals/sampling algorithms implemented.  
 
An alternative to standard ensemble generation methods rely on the use of multi-level (ML) 
approaches, where the conformational space is reduced to a small set of conformations whose 
relative stability is evaluated by means of accurate quantum mechanical (QM) calculations 9,10. These 
methods can provide high quality estimates and are reasonably free of parametrization artefacts, 
but are slow, and have not been implemented in automated workflows, which severely hamper 
their use in the context of pharmaceutical research. Furthermore, as QM calculations are not 
typically integrated in standard workflows and automated pipelines, the results obtained by ML 
calculations remain disconnected from the mainstream of rational drug design projects. Finally, as 
the derived information is not maintained in an interoperable format, its re-use by external users in 
processes of re-parametrization, description of interacting properties, machine learning or QSAR-
type is challenging.  
 
We present here a fully automated workflow for the exploration of the ligand conformational space. 
The procedure starts with a simple description of the drug (e.g.: chemical drawing, SMILES, Chembl 
code, PDB code) and performs all the steps to sample the conformational space with Hamiltonian 
Replica Exchange (HREX) 11,12  molecular dynamics simulations at the classical level. The 
conformational space is then reduced to a small number of representative conformations by 
clustering, with each cluster representative being then refined through QM/SCRF calculations 13. All 
the process of generating conformers is automatized and packed in a webserver to facilitate its use 
by non-experts. The conformational ensembles at the classical and QM levels are stored in the 
bioactive conformational ensemble (BCE) database, where many descriptive analyses performed on 
the ligands are also available. The database is free and accesible through a graphical web-based 
interface which allows access to a combination of interactive 3D representations and 2D plots. The 
server allows the user to define a private workspace to launch simulations and the REST API offers 
programmatic access to all the information stored in the database. A deposition protocol is available 
to accept the submission of new molecules so that the database can become a repository for the 
community. Input files are provided on demand for those cases where calculations must be carried 
out locally at user’s computer facilities.  
 




BCE GENERAL STRUCTURE 
 
The BCE framework consists in a server from which the workflow necessary to generate 
representative conformers can be launched from a private workspace, a database where results can 
be stored and a graphical interface that allows the analysis of all the data (see Figure 1).  Several 
links allow the connection of the BCE entries with external biological databases and associated tools. 
Programmatic access to the database is possible to facilitate high-throughput meta-analysis of the 
data. BCE can incorporate data from external users, which facilitates its growth and long-term 
sustainability and allows the definition of subsets of data, for example, drugs targeting a given 
protein, or families of drugs with a given pharmacological activity. The BCE database is conceived as 
an open initiative working with non-confidential information, which can be shared with the 
community. However, the BCE server offers a private workspace, and allows downloading of input 
files for “in house” calculations in cases where confidentiality is a must. Downloading input files may 
be required to use license-protected software, or the extension of simulations beyond the defaults. 




Figure 1. The bioactive conformational ensemble (BCE) framework. The front-end part (left-hand) 
shows the user interface containing the web-based graphical interfaces for the server and the 
database, together with the REST API programmatic access. The back-end part (right hand) contains 
the infrastructure behind the framework, consisting on a distributed noSQL database and a private 
cloud infrastructure with on-demand deployment, both connected to the front-end by means of a 
central Virtual Machine. 
 
THE BCE SERVER  
 
The BCE server is built as a web interface, which allows the automatic launching of a workflow 
intended to generate reliable conformational ensembles for a particular compound. The workflow 
consists on a series of building blocks that generate topologies and initial structures of the molecule, 
define approximate force-field parameters, and derive and process classical ensembles to finally 
obtain representative conformations. Those conformations can be then submitted to QM 
calculations for further refinement (see general scheme in Figure 2 in this paper and a specific 
version of the workflow in a previous companion paper). Once calculations are finished, the server 
offers a variety of analyses on the data and the possibility to upload the results into the BCE 






Figure 2. BCE pipeline schematic figure. From an input ligand, a 3D structure is generated (if needed), 
force-field parameters are determined, and classical ensembles computed with enhanced sampling 
calculations. A last step is refining the structures in a quantum level, to finally obtain accurate 
representative conformations 
 
The server is defined in two main blocks: a section to create new projects and a private user 
workspace, where projects for a user can be explored and stored for a limited period of time. 
 
CREATE NEW PROJECT 
 
1. Upload Data. The pipeline outlined starts by first introducing the molecule of interest. This can 
be done using a variety of procedures: 
 
 SMILES: The SMILES 14 signature can be used as input, and also as a query for searching for 
a similar structure (with a modifiable similarity index) or a substructure from the Chembl 
or PDB databases. 
 
 Chemical Drawing: the compound can be drawn from scratch, or can be modified from a 
starting SMILES code, using the ChemAxon Marvin chemical editor 15 (Fig. 3A). Tanimoto´s 
16 similarity search from the drawn molecule is performed to fetch similar compounds from 
the Chembl (for 2-D bioactive drug-like small molecules 17 ), or the PDB (for experimental 
3D structures 18 ) databases. 
 
 Browse: The server allows the user to search compounds from keywords contained in the 
molecule name (Chembl, PDB), or in the header/compound of a PDB structure. 
 
 Upload PDB file: Drag and drop or choose a PDB file. Selection of the ligand to be studied 
(if the structure has more than one) is possible thanks to an integrated graphical viewer 
(Fig. 3B). 
 
 PDB code, Ligand code: Start the project from a known PDB code and/or ligand 3-letter 
code. The list of ligands contained in the structure represented by the PDB code is 
automatically retrieved. 
 
In all the cases, if more than one possible molecule is found (e.g. from a similarity search), a 
table containing the list of compounds is presented (Fig. 3D).  Each of the entries from the table 
can be expanded to retrieve data from Chembl, PubChem 19 and PDB databases for the 
particular molecule, such as pharmacological information, 2D and 3D representation, and 
chemical descriptors.  
 
2. Protonation State. Once the molecule has been chosen, all the possible (de)protonation states, 
are computed in the entire range of pH and graphically displayed (Fig. 3C). From all the different 
states generated, the major form of the molecule at pH 7.4 is highlighted. If the user uploads a 
known protonated input structure, this step can be skipped. After testing several tools we decided 
to determine protonation states using the Chemaxon tool, which also ranks all the possible 
tautomeric forms for a given protonation state 15. The user can use the QM-tools coupled to the 
server to perform a more accurate tautomerism analysis. 
 
3. Settings. Finally, the user can select a minimum set of options for the HREX simulations such as 
the number of replicas or the initial and final temperatures (scaling factors). Although the number 
of replicas and/or length of the simulations was set in our server after careful benchmark with 
experimental data (see companion paper ct-2020-00304y), some external user may want to extend 
or personalize our setup. For these cases, all input configuration files to run the simulations locally 
can be found and downloaded from the user workspace (see  
next section). The user can also select some clustering options (defaults are provided). Due to 
licensing and computational restrictions we cannot offer QM calculations to external unregistered 
users, but we offer all the required files in Gaussian 20 format. As shown in a companion paper 
reasonable results can be obtained at the MST/DFT B3LYP/6-31G(d) level of theory (the default 
setting provided to the user), but the user is free to choose his/her own code. Once QM calculations 
are done the user can integrate the data into the server to take advantage of analysis data in BCE 





Figure 3. Screenshots showing examples of different web server interface sections.  
A) Input from a chemical drawing. ChemAxon Marvin JS is used as a chemical editor. An initial 
compound can be drawn from a SMILES code and modified afterwards. The compound drawn can 
be used as a substructure search to Chembl and PDB databases. B) Highlight of an intermediate page 
for a 3D-structure input. The interface automatically identifies the different ligands included in the 
structure, presents them to the user, and gives the option to choose one. NGL is used to interactively 
visualize the 3D structure. C) Possible protonation states computed by the server and offered to the 





The Bioactive Conformational Ensemble web server is built from a centralized personalized 
workspace (Fig. 4). Registration is not required to test the server, but results generated without 
registration will be kept in our disks for just 7 days. Completed projects are automatically transferred 
to a user workspace if a registration process is performed afterwards. Registered users have a 
persistent workspace, with 2GB of disk quota, which can be extended upon request. A 
demonstration user is available to play with the workspace interface with pre-computed projects.  
 
Every new project is appended to the user workspace in the files structure (Fig. 4A), mimicking a 
new folder from a file system environment. Files belonging to a certain project are revealed in a 
folder content (Fig. 4B). User jobs submitted, running or already finished are listed in the jobs section 
(Fig. 4C). Disk quota left is shown in the last section of the graphical workspace (Fig. 4D). Action 
buttons associated to every generated file offer a set of functions that varies depending on the file 
type. Common functionalities are “download” and “delete”. Specific functionalities include 
visualization of a 2D structure Kekule 21, a 3D structure NGL 22, or a plain text. Every project has an 
associated summary button, which opens a graphical summary of the project results, described 
below.  
 
Finished projects can be directly uploaded to the BCE database to make them publicly available to 
the scientific community. In the case where QM-refined conformations are computed locally in the 
users’ facilities, the new ensemble can be uploaded and associated to a particular BCE project. In all 
cases, manual curation will be performed, to ensure correctness and completeness. This curation 
protocol and the instructions to submit new molecules can be found in the supplementary material 




Figure 4. Screenshots showing examples of the web server private workspace. The files structure 
section (A) shows the list of projects for the particular user. All the files generated for a selected 
project are presented, in a file-system manner, in the folder content section (B). User jobs 
submitted, running or already finished are listed in the jobs section (C). Disk quota left is shown in 
the last section of the graphical workspace (D). 
 
 





The BCE database contains for each molecule, a classical conformational ensemble in solution 
together with a set of cluster representatives derived from it, their QM-optimized geometries and 
energies, and several associated analyses. The “bioactive conformation” as derived from X-ray 
crystallography is displayed when available. For practical terms the database is divided internally in 
logical data sets that are saved as subsets. The entire database presented here can be then 
subdivided to tackle different subsets, which might have different input and output needs. For each 
compound representative conformations are stored and presented (data for symmetry equivalent 
conformers are grouped). We typically show ten diverse and highly populated conformers for which 
classical and QM data are displayed together with a set of analyses useful for quantitative structure–
activity relationship (QSAR) and Structure-based drug design (SBDD) studies. At present time, the 
database contains data for around 1000 conformers of ~115 compounds and occupies around 1 Tb 
of disk. All trajectories were stored for further analysis using MD database recommendations 23.  
 
 
ANALYSIS IN THE DATABASE 
 
Entries in the database are divided in six different sections or tabs (see Fig. 5A). General information, 
pharmacological properties and 2D/3D representations of the molecule are presented in the 
Molecule tab (Fig. 5B). Lipinski 24 and Veber’s rules 25 are computed and shown in two independent 
tables. Compliance with the specific points of these rules is also integrated with the DB search 
engine (see search section). Links to entries from a list of pharmacologically relevant libraries for the 
particular compound are available, when applicable (PubChem 19, DrugBank 26, SureChembl 27, 
Chembl 17, ChEBI 28, Therapeutic Targets Database (TTD) 29, BindingDB 30, ZINC 31). If the molecule 
studied has an associated experimental structure, a link to the RCSB PDB ligand interaction 3D view 
section is automatically added, to explore experimental binding mode.  
 
The set of parameters (metadata) used in the biased MD simulation, together with a molecular 
representation of the total number of snapshots computed (typically 10,000) can be found in the 
Trajectory tab (Fig. 5C). This section includes statistics of exchanges from the biased MD, and 
flexibility and shape adjustments through Root Mean Square deviations (RMSd), Radius of Gyration 
and Atomic Fluctuation analyses.  
 
The Principal Component Analysis (PCA) section presents essential deformation movements 32 of 
the ligand as determined from the 10 first modes (those representing most of the conformational 
variance). Motions are represented using NGL, and projections of the snapshots to the first 3 
principal components are used to easily identify the space explored by the trajectory snapshots, and 
the space covered by the final set of chosen conformers (Fig. 5E). Such a set is shown in the Clusters 
section. The number of different conformers is adjusted to represent 95% of the variability of the 
computed trajectory. Trajectory population and convergence of the chosen clusters are shown. 
Conformer’s 3D structures are rendered in NGL in interactive plots where each individual conformer 
(and the experimental one if available) can be shown, hidden, or compared with the others. We 
have found that these plots are a fast an intuitive way to check convergence (see Suppl. Figure S1 
for a side-be-side comparison of convergence as measured by looking at “reference” replica and by 
looking at the average population of the conformers at the different replica trajectories). Cross 
RMSd of cluster representative and RMSd with respect to the experimental structure (if available) 
are given. Relative population of cluster and their associated relative Gibbs free energies are 
presented in an associated table referred always to the most stable cluster. Several tests showed us 
that the statistical errors associated to cluster population are small and we decided then to do not 
include error bars in the graphs (see Suppl. Figure S2), the user can always get an estimate by 
fractioning the global trajectory. When the bioactive conformation is known, the strain and 
distortion free energies obtained from the cluster populations are shown (see companion paper ct-
2020-00304y). A final subsection of the Clusters analysis represents Molecular Interaction Potential 
(MIPs; 33) for the set of conformations. NGL is used again to represent the grids coming from three 
different MIP probes: positive, negative and neutral. The interface represents two different 
conformers at the same time, so that they can be easily compared.   
 
The Dihedrals section allows users to explore the molecule’s dihedrals flexibility (Fig. 6), which is 
useful to determine which torsions are contributing the most to define the molecular 
conformational space, something very useful for force-field refinement. By default we are using for 
the database generation simulations derived from the GAFF FF 34 , which has demonstrated a good 
performance in different tests 35–37, but in a companion paper we show how GAFF FF parameters 
can be improved from the QM data shown in the server. Obviously, the user is free to use other 
force-field in the simulations. By default, we used minimum salt condition (i.e. that required to 
achieve electroneutrality, which agree with the default SCRF methodology used at the QM level). 
However, the user is free to consider other salt conditions; in our experience for most small 
bioactive molecules, differences between minimum salt and physiological conditions are negligible.  
Using an interactive approach, users can click on a desired dihedral, or just select one from the table 
(categorized as flexible, flexible ring, rigid and rigid ring). A polar plot and an associated histogram 
are automatically generated. Dihedral values corresponding to the chosen conformers and 
experimental bioactive conformation (if available) are represented on top of the trajectory values.  
 
The final section, Quantum Mechanics (QM), presents the data for the different conformations 
optimized at the QM level. NGL is used again to show the 3D structures, and the associated table is 
now presenting (free) energies (internal energy and solvation free energy as determined from 
DFT/SCRF calculations; Fig. 5D) taking the most stable conformation as reference. As described 
elsewhere (see companion paper ct-2020-00304y), by default no salt effects are included in SCRF 
calculations that were carried out by default using our MST version of the PCM method 13. If the 
bioactive compound (experimental) is available, QM tab shows an estimation of distortion and strain 






Figure 5. Screenshots showing examples of the different BCE database web interface sections 
(Compound BAC0010630, PDB id 2wd9-IBP). A) Section selection tabs. B) Molecule section: 2D and 
3D representation of the molecule. C) Trajectory section: metadata information (top) and 3D 
trajectory structure representation (down). D) QM section: energies for all conformers chosen after 
QM optimization (middle table), with their structural representation (down). Distortion and strain 
free energies between the bioactive conformation (PDB) and the conformer with best relative 
energy are shown in a green colored box (top), when available. Note that the boxes change their 
color to red if no conformer with energy better than the experimental bioactive conformation has 
been found. E) PCA section: Snapshots projections to the first and second principal components. 
Brown dots correspond to the 10,000 trajectory snapshots. Green triangles represent the cluster 
conformations chosen from the trajectory, representing most of the conformational landscape. Red 
square belongs to the experimental bioactive conformation and is represented when available for 







Figure 6. Detail of the Dihedrals analysis section. A) List of dihedrals, classified in five categories: 
Flexible, Rigid, Rigid-Ring and Flexible-Ring. When hovering the mouse over the table, the particular 
dihedral is highlighted in the structure, and the other way around. Clicking on one of the dihedrals 
opens two different plots: B) Polar plot representing the polar region covered by the particular 
torsion; and C) Line plot representing the dihedral values for the particular torsion along the whole 
trajectory (10,000 snapshots in this case), with its associated histogram. Experimental (if available) 
and conformations torsion values are appended to the plots, identifying the regions sampled. 
 
SEARCHING & BROWSING 
 
Following the FAIR data principles 38, a unique and persistent identifier is assigned to each of the 
entries in the database (e.g. BAC0010630), allowing a direct link to a particular compound. The web 
interface allows searching the database by molecular similarity or from a set of molecular 
properties. In the search by similarity section, a substructure can be introduced either from a SMILES 
code or from a drawn 2D representation using ChemAxon Marvin chemical editor. The engine is 
then searching the substructure within the compound database using Tanimoto´s similarity search. 
In the search by parameters section, 3 different subsections allow the user to search by molecule 
description (e.g. name, id), molecule properties (e.g. number of heavy atoms, hydrogen bond 
donors/acceptors) and simulation results. The possibility to filter those molecules fulfilling Lipinski’s 
24 or Veber’s 25 rules is also integrated, which facilitates focusing the analysis in drug-like molecules. 
Direct access to a browsing table listing all compounds included in each of the database’s subsets is 
also available. Search results are presented using the same table interface, which also allows the 
user to search for important keywords such as BCE id, name, subset name or fulfillment of drug-like 
rules. 
 
UPLOAD OF NEW COMPOUNDS  
 
The incorporation of new compounds in the database is possible in two different ways: a direct file 
upload to BCE database web interface, or a BCE server job submission. For the direct upload, 
metadata should be provided in a deposition protocol. Manual curation of every entry will be done, 
to ensure correctness and completeness. This curation protocol and the instructions to submit new 
molecules to the database can be found in the supplementary material. Jobs run from the web 
server, when available, could be eventually made public or kept on-hold depending on project’s 
requirements. New compounds either uploaded from the database interface or computed from the 
server will be added to the Users’ Uploads subset, with the possibility to generate new subsets 
connected to a project if applicable. 
 
DOWNLOAD AND PROGRAMMATIC ACCESS  
 
The simulated trajectory, cluster structures and optimized conformations can be downloaded from 
the web interface, as well as be accessed programmatically via a REST API, which facilitates high 
throughput analysis and meta-analysis. Services are grouped following the same sections as the web 
server interface, with an additional division for analysis and files. The complete list of endpoints, 
together with examples on how to use them, can be found in Suppl. Table S1.  An extensive 
documentation, with examples and the possibility to modify input parameters and run/test the 





The BCE web server has been implemented using the Slim PHP micro-framework 
(https://www.slimframework.com/) following a Model-view-controller (MVC) architectural pattern 
39. NGL 22 is used to visualize 3D structures and trajectories, Kekule js 21 is used to visualize 2D 
structures, and AmCharts javascript package (https://www.amcharts.com/), with modern data 
interactive visualization, was chosen to display all the analysis plots. Chemaxon Marvin is used for 
drawing, displaying and characterizing chemical structures, (Marvin 17.5.0, 2018, ChemAxon, 
http://www.chemaxon.com). The BCE API is documented using the SwaggerTM (http://swagger.io) 
API framework.  
 
User’s workspaces and database entries information are stored using a noSQL MongoDB 
(https://www.mongodb.org). This ensures the flexibility in data representation needed to efficiently 
store and access the variety of heterogeneous data generated by the project, from the trajectory 
metadata and analyses to the set of generated files and their folder hierarchy (MongoDB’s GridFS). 
Complete replicas of the Protein Data Bank 18, Uniprot 40 and Chembl 17 are stored in the same 
MongoDB infrastructure for efficiency purposes. The server is linked to these DB mirrors, with 
additional queries to the original DBs through REST API calls within error control flow. Values shown 
in the molecule section of the analysis division were automatically fetched from PDB 18 and 
PubChem (PUG-REST) REST 41 APIs at the time of upload, and stored in the internal database for the 
sake of completeness and efficiency. Persistence of the workspace is guaranteed with user 
registration. Single Sign On (SSO) access control is implemented, allowing the possibility to login 
using a Google, LinkedIn or ELIXIR account.  
 
Input molecules are converted to 3D structures (when needed) using OpenBabel chemistry toolbox 
42. Protonation states are determined using ChemAxon Calculator module 43. Details on the pipeline 
implemented in the BCE server to generate the conformational ensemble and the software used are 
presented in a companion paper. Briefly, all MD simulations are run using GROMACS 44 patched with 
PLUMED 45,46 and the HREX implementation 47. Principal Component Analysis is computed using 
pcasuite package 48. Molecular Interaction Potential grids are computed using CMIP program 33. 
RMSd, radius of gyration, atomic fluctuation, conformational clusters and dihedral angles are 
computed using the analysis tools integrated in the Gromacs MD package 44. Symmetry-corrected 
RMSds are computed using cpptraj tool 49 from the Ambertool MD analysis package 50. 
 
Jobs are queued using Open Grid Scheduler (OGS) manager (http://gridscheduler.sourceforge.net), 
and served in an on-demand processing model performed by Virtual Machines automatically 




SOME EXAMPLE APPLICATIONS 
 
In this section we provide a few examples of the power of the database and associated server. The 
low throughput methodology used to generate the BCE database yields ensembles capturing details 
that are out of reach for the traditional, quick conformational generation methods. Exhaustive 
sampling coupled to quantum mechanical calculations allows spotting errors in the assignment of 
conformations in X-ray crystal structures as well as reproducing important phenomena considered 
by medicinal chemists while optimizing their chemical series such as intramolecular repulsion, sigma 
hole effects 52, unconventional geometries for saturated rings or the effect of a “magic methyl” 53. 
Here are a few examples of the insight derivable from the BCE database.    
 
Example 1. Quality check.  
 
A search for compounds with a ΔΔG > 5 kcal/mol between the lowest energy conformer as predicted 
by the HREX/QM calculations and the experimental receptor-bound conformation as found in the 
PDB yields a total of 8 instances. As expected, most of them are very flexible ligands, but 
BAC0010568 (Donepezil, 1eve-E20), with only 6 rotatable bonds (excluding the piperidine ring) is 
also in the list, as simulations suggest that the most stable conformation (carbon atoms in pink in 
Figure 7) is at about 5 kcal/mol below the bioactive conformation (carbon atoms in cyan Figure 7). 
Analysis of the X-ray structure  of the acetylcholinesterase (AchE)-E20 complex shows that Donepezil 
is completely embedded into the gorge of AchE 54, which might justify the large conformational 
penalty 55. When rigidly docked 56 the global minimum conformation nicely fits into the AchE gorge 
also involving a direct cation-pi interaction with AchE Phe330 via its piperidine nitrogen (Figure 7A, 
green dotted line). More interestingly, the BCE-generated most stable conformation is also 
compatible with the experimental electron density of Donepezil (Figure 7B). Thus, the insight from 
using the BCE ensemble is twofold: i) quantify the energetic penalty paid by Donepezil to achieve its 
protein-bound state; ii) suggest that the AchE-E20 complex could include an E20 conformation 














Example 2. Sigma hole effect 
The role of non-covalent sulfur interactions in protein-ligand recognition is often explained through 
the “σ-hole” interaction 52, which is generated by the interaction of positive electrostatic potential 
around sulfur atoms in heterocycles such as thiophene or thiazole with the lone pair of hydrogen 
bond acceptors (e.g. nitrogen and oxygen atoms). It is expected that “σ-hole” interactions might 
have also a role in determining ligand conformation, but in the absence of specific corrections to 
the force-field, this is not captured in classical simulations. We found a nice example of “σ-hole” 
mediated conformation in the system 3tki-S25 (BAC0010644). The S25 ligand binds Chk1 kinase in a 
bioactive conformation where the thiazole sulfur atom is engaged in an intra “σ-hole” interaction 
with the pyrimidine nitrogen atom (Fig. 7C). The application of our pipeline to this ligand yields an 
ensemble where the lowest energy conformer (Fig. 7D) indeed has an intramolecular sigma hole 1,5 
N···S interaction. Interestingly, the conformers without this sigma hole interaction are less favored 
energetically, with at least a penalty of ∆𝐺 =3.22 kcal/mol (Fig. 7E). Thus, an accurate potency 
estimation for this congeneric series is beyond reach when ignoring this intramolecular interaction.  
 
Example 3. Magic methyl  
 
Medicinal chemists name “magic methyl” effect to the dramatic increase in potency caused by the 
introduction of a methyl substituent at specific positions. It has been shown 53 that such an increase 
is not only due to hydrophobic contacts, but also to conformational biases towards the bioactive 
conformations. One example we found in our database was pdb complex 3d7z-GK5 (BAC0010631). 
The GK5 inhibitor binds p38MAP kinase in a bioactive conformation where the adjacent phenyl rings 
must be placed at ca. 90 degrees for optimized potency (Fig. 7F). GK5 molecule and its close de-
methylated counterpart (BAC0010632) were run through the pipeline and their ensembles studied 
in detail. Our results show (Fig. 7G) that the second most stable QM conformer for the pdb ligand is 
equivalent to the bioactive conformation, while reaching the bioactive conformation implies a large 
penalty (∆𝐺 = 2.75 kcal/mol) for the demethylated compound where the aromatic rings tend 

















































Figure 7. (A, B) Application of BCE server to study the complex between Acetylcholinesterase and 
Donepezil (AchE-E20). A) Lowest QM energy conformer (pink color; ΔGstrain=0) of Donepezil rigidly 
docked into AchE and the X-ray bioactive structure (in cyan; ΔGstrain=5.21 kcal/mol) with proximal 
AchE residues engaging with piperidine Nitrogen; dotted green and blue lines highlight interactions 
between the piperidine Nitrogen in the docked most-stable conformer and X-ray binding mode, 
respectively; distances are shown in Angstroms. B) Superposition of the BCE-generated most stable 
C)                                              D)                                               E) 
F)                                              G)                                               H) 
conformer (pink color) and the crystallographic conformation of Donepezil (in cyan); the 
experimental 2fo-fc electron density map contoured at 2.0 sigma is shown as grey mesh. (C, D, E) 
Example of sigma hole effect in the 3tki-S25 system (BAC0010644). C) Close up on the 
crystallographic protein-bound conformation of ligand S25; “σ-hole” interaction highlighted by 
dotted line. D) Lowest energy conformer as found in the BCE ensemble, with the “σ-hole” interaction 
also present (highlighted by dotted line); E) A conformer where no “σ-hole” interaction takes place, 
leading to a penalty of 3.22 kcal/mol. (F, G, H) Example of magic methyl present in 3d7z-GK5 
(BAC0010631) and absent in 3d7z-GKN (BAC0010632). F) Experimental bioactive conformation for 
BAC0010631; G) Second lowest energy conformer for the same molecule. The phenyl rings are 
almost perpendicular to each other, similarly to the orientation observed experimentally for the 
protein-bound conformer; H) Second lowest energy conformer when methyl is absent showing the 




CONCLUSIONS AND FUTURE DIRECTIONS 
 
We present a new structure-based drug discovery framework to generate accurate bioactive 
conformational ensembles of small molecules obtained by a theoretical multilevel strategy 
combining MM and QM. A web-based private workspace allows running the pipeline on a desired 
ligand, whereas the associated database and API allows the generated conformers to be publicly 
available in a FAIR-compliant way. The number of conformers offered by the BCE database will grow 
with new subsets currently being computed in our group (e.g. Central Nervous System-related 
compounds analyzed in the context of the Human Brain Project). Besides, upload of new ensembles 
is possible for the community to extend the database. The BCE framework is designed to become a 
repository for the computer-aided drug design community to find and deposit accurate structural 
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